Session

23.09.2021     15:30–16:30

Titel:
Postersession 1
PS-1: Blutspende und Donormanagement | Versorgungsforschung| Blutkomponenten – Herstellung und Qualitätskontrolle | Präparative und Therapeutische Apherese | Infektionssicherheit von Blutprodukten | Hämovigilanz
Art:
Postersession – Zoom-Meeting

23.09.2021
15:30–16:30

Titel:
Postersession 1
PS-1: Blutspende und Donormanagement | Versorgungsforschung| Blutkomponenten – Herstellung und Qualitätskontrolle | Präparative und Therapeutische Apherese | Infektionssicherheit von Blutprodukten | Hämovigilanz
Art:
Postersession – Zoom-Meeting


15:30–15:35
PS-1-1 How does the Corona pandemic impact on whole blood donation in Germany?
Simon Ehrhart (Mannheim/DE)
Redezeit: 3 + 2 min


15:35–15:40
PS-1-2 Prevalence and regional distribution of Verweyst (Vw) blood group antigen in Southeast Switzerland – Detection of a local hotspot
Saara Roininen (Schlieren/CH)
Redezeit: 3 + 2 min


15:40–15:45
PS-1-3 German hemophilia registry: Users have their say
Christine Keipert (Langen/DE)
Redezeit: 3 + 2 min


15:45–15:50
PS-1-4 Performance of top & bottom in-line red blood cells (RBC) sets with DEHP-free bags and DEHP-free RBC leukoreduction filter: a validation study
Connie Stoeckel (Frankfurt/DE)
Redezeit: 3 + 2 min


15:50–15:55
PS-1-5 Isoagglutinins in the residual plasma of red blood cell concentrates - Indication for pre-transfusion washing for children or not?
Barbara Gringinger (Linz/AT)
Redezeit: 3 + 2 min


15:55–16:00
PS-1-6 Factors affecting the quality of CD34+ cell selections of autologous and allogeneic hematopoietic stem/progenitor cell (HSPC) grafts
Soo-Zin Kim-Wanner (Frankfurt/DE)
Redezeit: 3 + 2 min


16:00–16:05
PS-1-8 High levels of contaminating lipids or red blood cells do not affect the inactivation capacity of the THERAFLEX UV-Platelets system
Ute Gravemann (Springe/DE)
Redezeit: 3 + 2 min


16:05–16:10
PS-1-9 Evaluation of Delta-He as a screening parameter for unspecific immune activation in blood donors
Susanne Suessner (Linz/AT)
Redezeit: 3 + 2 min


16:10–16:15
PS-1-10 Effect of methylene blue pathogen inactivation on integrity of immunoglobulin M and G
Johannes Raster (Greifswald/DE)
Redezeit: 3 + 2 min


16:15–16:20
PS-1-11 BloodTrain: Establishing and strengthening haemovigilance systems in Africa
Joanna Atemnkeng (Langen/DE), Jens Reinhardt (Langen/DE)
Redezeit: 3 + 2 min


16:20–16:25
PS-1-12 Acute and severe hemolysis associated with high-dose intravenous immunoglobulin administration
Alaa El-Hammoud (Berlin/DE), Beate Mayer (Berlin/DE)
Redezeit: 3 + 2 min